Qube Research & Technologies (QRT)’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,404,038	Closed	-$3.55M	–	5020
2023 Q4	$3.55M	Buy	+1,404,038	New	+$3.27M	0.01%	1222
2023 Q1	–	Sell	-473,084	Closed	-$1.19M	–	3148
2022 Q4	$1.19M	Buy	473,084 +131,378	+38%	+$367K	0.01%	1148
2022 Q3	$991K	Buy	341,706 +271,617	+388%	+$1.14M	0.01%	1209
2022 Q2	$317K	Sell	70,089 -77,242	-52%	-$460K	﹤0.01%	1572
2022 Q1	$1.18M	Buy	147,331 +75,540	+105%	+$666K	0.01%	1085
2021 Q4	$836K	Buy	+71,791	New	+$860K	0.01%	1298

Qube Research & Technologies (QRT)'s SLGC Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 1,404,038 shares — an estimated $3.55M sold.

Qube Research & Technologies (QRT) first reported a position in SLGC in Q4 2021 and held it in 6 quarters. The position peaked at $3.55M in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Qube Research & Technologies (QRT) reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 1,404,038 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $3.55M.
Qube Research & Technologies (QRT) first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s SomaLogic, Inc. Class A Common Stock position peaked at $3.55M in Q4 2023.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.